Promising Bimarker Prediction of Outcome of HELLP Syndrome.
Association Between the Quantitative Assessment of Schistocytes in Peripheral Blood Smear and Prognosis of Patient Initially Diagnosed as HELLP Syndrome.
1 other identifier
observational
100
0 countries
N/A
Brief Summary
HELLP syndrome is a life-threatening obstetric complication usually considered to be a variant or complication of pre-eclampsia. And may occasionally be confused with other diseases complicating pregnancy such as acute fatty liver of pregnancy, gastroenteritis, hepatitis, appendicitis, gallbladder disease, immune thrombocytopenia, lupus flare, antiphospholipid syndrome, hemolytic-uremic syndrome, thrombotic thrombocytopenic purpura, and nonalcoholic fatty liver disease. The distinction between thrombotic thrombocytopenic purpura-hemolytic uremic syndrome and severe preeclampsia is important for therapeutic and prognostic reasons. However, the clinical and histological features are so similar that establishing the correct diagnosis is often difficult; furthermore, these disorders may occur concurrently.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2015
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 23, 2017
CompletedFirst Posted
Study publicly available on registry
August 11, 2017
CompletedAugust 11, 2017
August 1, 2017
11 months
July 23, 2017
August 9, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
laboratory changes after 48 hours of delivery
full blood count, liver function tests( AST, ALT, Bilirubin), kidney function (serum creatinine level), coagulation profile (INR, PTT, PT)
48 hours
Interventions
Eligibility Criteria
A total of 100 women with an initial diagnosis of HELLP syndrome were recruited in the study. Blood sample taken within 12hrs peripartum and patients followed up 48hrs after delivery and subdivided in to 2 groups according to improvement or deterioration after 48hrs after delivery .
You may qualify if:
- Gestational age more than 20 weeks.
- Age from18 to 40 years old.
- Fulfilled criteria for the diagnosis of severe preeclampsia.
- Fulfilled criteria for the diagnosis of HELLP syndrome.
- Diagnostic criteria for severe preeclampsia(one of the following):
- Blood pressure of 160 mm Hg systolic or higher or 110 mm Hg diastolic or higher on two occasions at least 6 hours apart while the patient is on bed rest (unless antihypertensive therapy is intiated befor this time).
- New onest Cerebral or visual disturbances.
- Pulmonary edema or cyanosis.
- Sever persistant epigastric or right upper-quadrant pain unresponsive to medication and not accounted for by alternative diagnosis, or both.
- Impaired liver function as indicated by abnormally elevated blood concentration of liver enzymes (to twic normal concentration).
- Thrombocytopenia (platlet count less than 100, 000 per microliter.
- Diagnostic criteria for HELLP syndrome:
- Hemolysis documented by an increased LDH level and progressive anemia .
- Hepatic dysfunction documented by an LDH level \>600 IU/L, elevated liver enzymes documented by AST \>40 IU/L, ALT\>40 IU/L, or both .
- Thrombocytopenia documented by a platelet nadir less than 150, 000 cells/mm³. Thrombocytopenia is subclassified as class one HELLP syndrome: platelet nadir ≤50, 000 cells/mm³, class two HELLP syndrome: platelet nadir ≤100, 000 cells/mm³, or class three HELLP syndrome: platelet nadir ≤150, 000 cells/mm³..
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
July 23, 2017
First Posted
August 11, 2017
Study Start
January 1, 2015
Primary Completion
December 1, 2015
Study Completion
June 1, 2016
Last Updated
August 11, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share